About Academician Wang Xuehao
Academician Wang Xuehao (王学浩) is Professor and one of China's most distinguished hepatobiliary surgeons and liver transplant pioneers, affiliated with Renji Hospital, Shanghai Jiao Tong University School of Medicine. An Academician of the Chinese Academy of Engineering — China's highest honor in engineering and applied sciences — Academician Wang is widely recognized as one of the founding architects of modern liver transplantation in China and a global authority on hepatobiliary surgery, liver preservation, and transplant immunology.
Over a career spanning more than four decades, Academician Wang has performed thousands of liver transplantations and complex hepatobiliary operations, trained generations of China's leading transplant surgeons, and led the scientific advances in organ preservation, immunosuppression, and surgical technique that have transformed liver transplantation outcomes in China. His contributions to the field have been recognized with China's highest scientific awards, and his research has shaped both national and international standards for liver transplant practice.
Hospital Affiliation
Renji Hospital of Shanghai Jiao Tong University School of Medicine is one of China's top-ranked general hospitals and a national center of excellence in liver transplantation and hepatobiliary surgery. The liver transplantation program at Renji — one of the highest-volume programs in China — performs adult and pediatric liver transplantations including living donor, deceased donor, split liver, and ABO-incompatible transplants. The program is deeply integrated with Renji's hepatology, oncology, and critical care services, providing comprehensive multidisciplinary management for patients with end-stage liver disease, hepatocellular carcinoma, and complex biliary disorders.
Clinical Expertise
- Liver transplantation — deceased donor liver transplantation; living donor liver transplantation (LDLT); pediatric liver transplantation; split liver transplantation; ABO-incompatible transplantation; re-transplantation
- Hepatocellular carcinoma (HCC) surgery — liver resection for HCC; transplantation for HCC within and beyond Milan criteria; combined resection and ablation; recurrence management
- Complex hepatobiliary surgery — hilar cholangiocarcinoma (Klatskin tumor); intrahepatic cholangiocarcinoma; gallbladder cancer; complex bile duct reconstruction; portal vein reconstruction
- Benign liver disease surgery — hepatic echinococcosis (hydatid disease); large hepatic hemangioma; complex liver cysts; hepatolithiasis
- Transplant immunology — immunosuppression optimization; acute and chronic rejection management; tolerance induction protocols
- Organ preservation — machine perfusion; extended criteria donor utilization; ischemia-reperfusion injury mitigation
Academic & Research Contributions
Academician Wang Xuehao's election to the Chinese Academy of Engineering reflects the transformative impact of his scientific contributions to transplantation medicine and hepatobiliary surgery. He has authored hundreds of peer-reviewed publications in leading surgical and transplantation journals, and his research on liver preservation, transplant immunology, and surgical technique has been cited extensively in international literature. He has received China's National Science and Technology Progress Award and multiple other national honors recognizing his contributions to transplantation medicine.
He has served in leadership positions in the Chinese Society of Organ Transplantation and the Chinese Society of Surgery, contributing to the development of national standards for liver transplantation practice and organ donation in China. His training program has produced many of China's current generation of leading transplant surgeons.
Why International Patients Choose Renji Liver Transplantation
For international patients requiring liver transplantation — whether for end-stage liver disease from viral hepatitis, autoimmune liver disease, metabolic liver disease, or alcoholic cirrhosis, or for hepatocellular carcinoma — Renji Hospital's transplant program offers world-class surgical expertise, a high-volume experienced team, and access to China's organ donation system at substantially lower cost than equivalent programs in Western countries. The combination of Academician Wang's pioneering legacy and the current team's technical excellence makes Renji one of the most compelling destinations globally for liver transplantation.
International patients also seek Renji's expertise for second opinions on transplant candidacy, evaluation of HCC for transplant versus resection, and management of post-transplant complications including rejection and biliary complications.
What to Expect at Your Consultation
Consultations begin with a comprehensive assessment including review of liver function, imaging (CT/MRI with volumetry), tumor markers, viral serology, and prior treatment history. CMCS will arrange certified translation of all prior medical records in advance. The team will outline transplant candidacy, waitlist considerations, living donor options, expected outcomes, and the full logistics of transplantation in Shanghai. A written English-language consultation summary is provided after every appointment.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking liver transplantation and hepatobiliary surgery at Renji Hospital, including priority consultation scheduling, certified medical translation, pre-consultation imaging review, transplant logistics coordination, and post-transplant follow-up support. Contact us at contact@medicalsh.com, or visit medicalsh.com.
0 commentaire